ArticleBMC infectious diseases2026
Integration of single-cell and bulk transcriptomics with machine learning identifies LDHA as a lactate-related diagnostic and prognostic biomarker in sepsis.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSepsis-induced metabolic dysregulation, particularly abnormal lactate metabolism, is closely associated with disease severity and mortality. This study aimed to systematically identify lactate-related genes involved in sepsis and evaluate their diagnostic and prognostic value using integrated transcriptomic analyses.
methodsSingle-cell RNA sequencing data were analyzed using AUCell, singscore, and ssGSEA algorithms combined with correlation analysis to identify lactate-related genes. A comprehensive machine learning framework incorporating 131 algorithms was applied for feature selection and construction of a diagnostic model. Survival analyses were performed to assess the prognostic significance of candidate genes. The expression of key genes was further validated by qPCR and western blotting in clinical samples and a sepsis animal model.
resultsSepsis patients were stratified into distinct molecular subgroups exhibiting significant differences in prognosis, clinical characteristics, pathway enrichment, immune infiltration, and immune checkpoint gene expression. Single-cell analysis revealed that MARCO⁺ macrophages exhibited relatively high lactate-related activity compared with most immune populations, while plasma cells showed comparable levels. Sixteen genes were identified at the intersection of macrophage differentially expressed genes and lactate-related genes. Machine learning analysis further identified six core diagnostic genes. Survival analysis demonstrated that high LDHA expression was significantly associated with poor prognosis in sepsis patients. Consistently, elevated LDHA expression was observed in septic animals compared with controls.
conclusionBy integrating single-cell and bulk RNA-seq data, we developed and validated a novel diagnostic model for sepsis, termed the Lacty Model, and identified LDHA as a key biomarker associated with poor prognosis. These findings highlight the potential clinical relevance of lactate metabolism–related genes in sepsis and provide a foundation for future mechanistic and therapeutic studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.